Low-dose naltrexone for the treatment of fibromyalgia: protocol for… (Abstract)

Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial Trials 15 November 2021 https://pubmed.ncbi.nlm.nih.gov/34781989/ Background: Low-dose naltrexone (LDN) is used widely as an off-label treatment for pain despite limited evidence for its effectiveness. A few small trials with a high risk of bias have investigated the effect of LDN on […]